Noninvasive monitoring of early antiangiogenic therapy response in human nasopharyngeal carcinoma xenograft model using MRI with RGD-conjugated ultrasmall superparamagnetic iron oxide nanoparticles
Yanfen Cui,1,* Caiyuan Zhang,1,* Ran Luo,1 Huanhuan Liu,1 Zhongyang Zhang,1 Tianyong Xu,2 Yong Zhang,2 Dengbin Wang11Department of Radiology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, 2MR Advanced Application and Research Center, GE Healthcare China, Shanghai, People&rsq...
Guardado en:
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2016
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/8503c157179644cf87b0635d198b418b |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:8503c157179644cf87b0635d198b418b |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:8503c157179644cf87b0635d198b418b2021-12-02T06:31:49ZNoninvasive monitoring of early antiangiogenic therapy response in human nasopharyngeal carcinoma xenograft model using MRI with RGD-conjugated ultrasmall superparamagnetic iron oxide nanoparticles1178-2013https://doaj.org/article/8503c157179644cf87b0635d198b418b2016-11-01T00:00:00Zhttps://www.dovepress.com/noninvasive-monitoring-of-early-antiangiogenic-therapy-response-in-hum-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Yanfen Cui,1,* Caiyuan Zhang,1,* Ran Luo,1 Huanhuan Liu,1 Zhongyang Zhang,1 Tianyong Xu,2 Yong Zhang,2 Dengbin Wang11Department of Radiology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, 2MR Advanced Application and Research Center, GE Healthcare China, Shanghai, People’s Republic of China *These authors contributed equally to this workPurpose: Arginine-glycine-aspartic acid (RGD)-based nanoprobes allow specific imaging of integrin αvβ3, a protein overexpressed during angiogenesis. Therefore, this study applied a novel RGD-coupled, polyacrylic acid (PAA)-coated ultrasmall superparamagnetic iron oxide (USPIO) (referred to as RGD-PAA-USPIO) in order to detect tumor angiogenesis and assess the early response to antiangiogenic treatment in human nasopharyngeal carcinoma (NPC) xenograft model by magnetic resonance imaging (MRI).Materials and methods: The binding specificity of RGD-PAA-USPIO with human umbilical vein endothelial cells (HUVECs) was confirmed by Prussian blue staining and transmission electron microscopy in vitro. The tumor targeting of RGD-PAA-USPIO was evaluated in the NPC xenograft model. Later, mice bearing NPC underwent MRI at baseline and after 4 and 14 days of consecutive treatment with Endostar or phosphate-buffered saline (n=10 per group).Results: The specific uptake of the RGD-PAA-USPIO nanoparticles was mainly dependent on the interaction between RGD and integrin αvβ3 of HUVECs. The tumor targeting of RGD-PAA-USPIO was observed in the NPC xenograft model. Moreover, the T2 relaxation time of mice in the Endostar-treated group decreased significantly compared with those in the control group both on days 4 and 14, consistent with the immunofluorescence results of CD31 and CD61 (P<0.05).Conclusion: This study demonstrated that the magnetic resonance molecular nanoprobes, RGD-PAA-USPIOs, allow noninvasive in vivo imaging of tumor angiogenesis and assessment of the early response to antiangiogenic treatment in NPC xenograft model, favoring its potential clinical translation. Keywords: magnetic resonance imaging, ultrasmall superparamagnetic iron oxide, integrin αvβ3, antiangiogenic therapy, Endostar, nasopharyngeal carcinomaCui YZhang CLuo RLiu HZhang ZXu TZhang YWang DDove Medical Pressarticlemagnetic resonance imagingultrasmall superparamagnetic iron oxideintegrin avβ3antiangiogenic therapyEndostarnasopharyngeal carcinomaMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 11, Pp 5671-5682 (2016) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
magnetic resonance imaging ultrasmall superparamagnetic iron oxide integrin avβ3 antiangiogenic therapy Endostar nasopharyngeal carcinoma Medicine (General) R5-920 |
| spellingShingle |
magnetic resonance imaging ultrasmall superparamagnetic iron oxide integrin avβ3 antiangiogenic therapy Endostar nasopharyngeal carcinoma Medicine (General) R5-920 Cui Y Zhang C Luo R Liu H Zhang Z Xu T Zhang Y Wang D Noninvasive monitoring of early antiangiogenic therapy response in human nasopharyngeal carcinoma xenograft model using MRI with RGD-conjugated ultrasmall superparamagnetic iron oxide nanoparticles |
| description |
Yanfen Cui,1,* Caiyuan Zhang,1,* Ran Luo,1 Huanhuan Liu,1 Zhongyang Zhang,1 Tianyong Xu,2 Yong Zhang,2 Dengbin Wang11Department of Radiology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, 2MR Advanced Application and Research Center, GE Healthcare China, Shanghai, People’s Republic of China *These authors contributed equally to this workPurpose: Arginine-glycine-aspartic acid (RGD)-based nanoprobes allow specific imaging of integrin αvβ3, a protein overexpressed during angiogenesis. Therefore, this study applied a novel RGD-coupled, polyacrylic acid (PAA)-coated ultrasmall superparamagnetic iron oxide (USPIO) (referred to as RGD-PAA-USPIO) in order to detect tumor angiogenesis and assess the early response to antiangiogenic treatment in human nasopharyngeal carcinoma (NPC) xenograft model by magnetic resonance imaging (MRI).Materials and methods: The binding specificity of RGD-PAA-USPIO with human umbilical vein endothelial cells (HUVECs) was confirmed by Prussian blue staining and transmission electron microscopy in vitro. The tumor targeting of RGD-PAA-USPIO was evaluated in the NPC xenograft model. Later, mice bearing NPC underwent MRI at baseline and after 4 and 14 days of consecutive treatment with Endostar or phosphate-buffered saline (n=10 per group).Results: The specific uptake of the RGD-PAA-USPIO nanoparticles was mainly dependent on the interaction between RGD and integrin αvβ3 of HUVECs. The tumor targeting of RGD-PAA-USPIO was observed in the NPC xenograft model. Moreover, the T2 relaxation time of mice in the Endostar-treated group decreased significantly compared with those in the control group both on days 4 and 14, consistent with the immunofluorescence results of CD31 and CD61 (P<0.05).Conclusion: This study demonstrated that the magnetic resonance molecular nanoprobes, RGD-PAA-USPIOs, allow noninvasive in vivo imaging of tumor angiogenesis and assessment of the early response to antiangiogenic treatment in NPC xenograft model, favoring its potential clinical translation. Keywords: magnetic resonance imaging, ultrasmall superparamagnetic iron oxide, integrin αvβ3, antiangiogenic therapy, Endostar, nasopharyngeal carcinoma |
| format |
article |
| author |
Cui Y Zhang C Luo R Liu H Zhang Z Xu T Zhang Y Wang D |
| author_facet |
Cui Y Zhang C Luo R Liu H Zhang Z Xu T Zhang Y Wang D |
| author_sort |
Cui Y |
| title |
Noninvasive monitoring of early antiangiogenic therapy response in human nasopharyngeal carcinoma xenograft model using MRI with RGD-conjugated ultrasmall superparamagnetic iron oxide nanoparticles |
| title_short |
Noninvasive monitoring of early antiangiogenic therapy response in human nasopharyngeal carcinoma xenograft model using MRI with RGD-conjugated ultrasmall superparamagnetic iron oxide nanoparticles |
| title_full |
Noninvasive monitoring of early antiangiogenic therapy response in human nasopharyngeal carcinoma xenograft model using MRI with RGD-conjugated ultrasmall superparamagnetic iron oxide nanoparticles |
| title_fullStr |
Noninvasive monitoring of early antiangiogenic therapy response in human nasopharyngeal carcinoma xenograft model using MRI with RGD-conjugated ultrasmall superparamagnetic iron oxide nanoparticles |
| title_full_unstemmed |
Noninvasive monitoring of early antiangiogenic therapy response in human nasopharyngeal carcinoma xenograft model using MRI with RGD-conjugated ultrasmall superparamagnetic iron oxide nanoparticles |
| title_sort |
noninvasive monitoring of early antiangiogenic therapy response in human nasopharyngeal carcinoma xenograft model using mri with rgd-conjugated ultrasmall superparamagnetic iron oxide nanoparticles |
| publisher |
Dove Medical Press |
| publishDate |
2016 |
| url |
https://doaj.org/article/8503c157179644cf87b0635d198b418b |
| work_keys_str_mv |
AT cuiy noninvasivemonitoringofearlyantiangiogenictherapyresponseinhumannasopharyngealcarcinomaxenograftmodelusingmriwithrgdconjugatedultrasmallsuperparamagneticironoxidenanoparticles AT zhangc noninvasivemonitoringofearlyantiangiogenictherapyresponseinhumannasopharyngealcarcinomaxenograftmodelusingmriwithrgdconjugatedultrasmallsuperparamagneticironoxidenanoparticles AT luor noninvasivemonitoringofearlyantiangiogenictherapyresponseinhumannasopharyngealcarcinomaxenograftmodelusingmriwithrgdconjugatedultrasmallsuperparamagneticironoxidenanoparticles AT liuh noninvasivemonitoringofearlyantiangiogenictherapyresponseinhumannasopharyngealcarcinomaxenograftmodelusingmriwithrgdconjugatedultrasmallsuperparamagneticironoxidenanoparticles AT zhangz noninvasivemonitoringofearlyantiangiogenictherapyresponseinhumannasopharyngealcarcinomaxenograftmodelusingmriwithrgdconjugatedultrasmallsuperparamagneticironoxidenanoparticles AT xut noninvasivemonitoringofearlyantiangiogenictherapyresponseinhumannasopharyngealcarcinomaxenograftmodelusingmriwithrgdconjugatedultrasmallsuperparamagneticironoxidenanoparticles AT zhangy noninvasivemonitoringofearlyantiangiogenictherapyresponseinhumannasopharyngealcarcinomaxenograftmodelusingmriwithrgdconjugatedultrasmallsuperparamagneticironoxidenanoparticles AT wangd noninvasivemonitoringofearlyantiangiogenictherapyresponseinhumannasopharyngealcarcinomaxenograftmodelusingmriwithrgdconjugatedultrasmallsuperparamagneticironoxidenanoparticles |
| _version_ |
1718399881904652288 |